Daniel Guay

Daniel Guay, PhD

Drug Development Advisor, Board Member

BIOGRAPHY

Dr. Daniel Guay is a seasoned executive with over 30 years of experience in drug development (Merck, Institute for Research in Immunology and Cancer (IRIC)) who contributed to bring several small molecule drugs to the market. In 2011, on behalf of AmorChem, he founded NuChem Therapeutics, a contract research organization centered on medicinal chemistry and small molecule discovery, acquired by Sygnature Discovery in 2023.

back to team